期刊文献+

咖啡因致胎儿宫内发育迟缓机制的研究进展 被引量:12

Mechanism underlying intrauterine growth retardation induced by caffeine and its research advance
下载PDF
导出
摘要 宫内发育迟缓(IUGR)是最常见的发育毒性之一,不仅可造成围产儿发病和死亡,而且其不良影响还可延续至成年,严重影响了人口生存质量。咖啡因广泛存在于多种日常饮料和某些药物中,其全球消耗量正逐年增加,妊娠妇女摄入含咖啡因的食品和药物也越来越多见。研究已证实,妊娠期摄入咖啡因是引起IUGR的危险因素之一,然而目前咖啡因引起胎儿不良反应的机制尚无定论。本文从母体(肾素-血管紧张素系统)、胎盘(细胞增殖/凋亡)和胎儿(神经内分泌干扰)3方面,综述了咖啡因致IUGR的发生机制。 Intrauterine growth retardation(IUGR) is one of the most commonly encountered developmental toxicity,which could lead to perinatal morbidity and mortality,be also extended from the fetus to adulthood,and seriously affect the quality of the population.Caffeine widely exists in a variety of daily beverages and some drugs.Its consumption is increasing year by year.Caffeine intake during pregnancy is one of the risk factors for IUGR.However,its mechanism of adverse outcome based on embryonic research is still unclear.In this paper,the possible mechanisms of caffeine-induced IUGR focusing on 3 important factors-the mother,placenta and fetus were explored.Caffeine's impact on the mother is the chronic activation of renin-angiotensin system;on the placenta,caffeine induces cell damage or the failure of the cell proliferation/apoptosis balance,leading to blockage of blood supply to the placenta;caffeine is also capable of directly affecting fetal development through interfering its neuroendocrine.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2010年第1期77-80,共4页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金重点项目(30830112) 国家自然科学基金资助项目(30672566) 国家自然科学基金资助项目(30800931) 国家大学生创新性实验项目(071048664)~~
关键词 宫内发育迟缓 咖啡因 胎儿 发育障碍 intrauterine growth retardation caffeine fetus developmental disabilities
  • 相关文献

参考文献34

  • 1Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation [ J ]. Horm Res, 1997, 48 (Suppl 1) :11 -16.
  • 2Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome [ J ]. Ann N Y Acad Sci, 2006, 1092 : 138 - 147.
  • 3Christian MS, Brent RL. Teratogen update: evaluation of the reproductive and developmental risks of caffeine[ J ]. Teratology, 2001, 64(1) :51 -78.
  • 4Barone JJ, Roberts HR. Caffeine consumption [ J ]. Food Chem Toxicol, 1996, 34( 1 ) : 119 - 129.
  • 5Fernandes O, Sabharwal M, Smiley T, Pastuszak A, Koren G, Einarson T. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis[J]. Reprod Toxicol, 1998, 12(4) :435 -444.
  • 6Fortier I, Mareoux S, Beaulae-Baillargeon L. Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth[J]. Am J Epidemiol, 1993, 137(9):931-940.
  • 7Thayer PS, Palm PE. A current assessment of the mutagenic and teratogenic effects of caffeine[ J]. CRC Crit Rev Toxicol, 1975, 3 (3) :345 -369.
  • 8Infante-Rivard C, Fernarndez A, Gauthier R, David M, Rivard GE. Fetal loss associated with caffeine intake before and during pregnancy [ J ]. JAMA, 1993, 270 (24) :2940 - 2943.
  • 9Grosso LM, Bracken MB. Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy[ J ]. Ann Epidemiol, 2005, 15 (6) :460 - 466.
  • 10Donoso P, O'Neill SC, Dilly KW, Negretti N, Eisner DA. Comparison of the effects of caffeine and other methylxanthines on [ Ca^2 + ].in rat ventricular myocytes[ J ]. Br J Pharmacol, 1994, 111(2) :455 -458.

二级参考文献21

  • 1Qiao S, Nagasaka T, Harada T, et al. p53, Bax and Bcl-2 expression and apoptosis in gestation trophoblast of complete hydatid from mole[J]. J Placenta, 1998,19(5 - 6) :361 - 369.
  • 2Yang T, Liu X, BhaUak, et al. Pretention of apoptosis by Bcl-2: release of cytochrome C from mitochondria blocked[J]. J Science, 1997,257(21):1129 - 1130.
  • 3Basanez C, Nechushtan A, Drozhinin O, et al. Bax, but not Bcl-xl decreses the lifetime of planar phospholipid bilayer membranes at subnaomdar concentrations [J]. J Proc Natl Acad Sci USA, 1999,96(10):5492-5497.
  • 4Marzioni D, Muhlhlhauser J, Crescimanno C, et al. Bcl-2 expression in the human placenta and its correlation with fibrin deposita[J]. J human Reprod, 1998,13: 1717 - 1722.
  • 5Nelson DM. Apoptotic changes occurs in syncytiotrrophoblast of placental villi where fibrinoid is desposited at discontinuities in the villous trophblast[J]. J Placenta, 1996,17:389 - 391.
  • 6Hupperts B, Frank HG, Kingdom JC, et al. Villus cytotrophoblast regulation of the syneytial apoptotic cascade in the human placenta[J]. J Histochem Cell Biol,1998,110:459 - 508.
  • 7Sata M, Walsh K. Endothelial cell apoptosis induced by oxidired LDL is associated with the down-regulation of the cellar caspase inhibiter FLIP [ J ]. J Biol Chem, 1998,388:119 - 127.
  • 8Roughton SA, Lareu RR, Bittles AH. Fas and Fas ligand messenger ribonucleic acid and protein expression in the rat carpas luteum during apoptosis mediated lateolisi[J]. J Biol Reprod, 1999,60(4) :797.
  • 9Hunts JS, Vassmer D, Tergusion TA, et al. Fas-L is positioned in mouse uterus and placenta to prevent tranfflicking of activated leukocytes between mother and the conceptus[J]. J Immunol, 1997,158:4112 - 4128.
  • 10Lin JH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family[J]. J Biochem Biophys Res Commun, 2000, 279 (3) : 820 - 831.

共引文献50

同被引文献130

引证文献12

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部